Drug Topics June 6, 2024
Killian Meara

HbA1c levels decreased significantly after an average of 154 days in patients who used a continuous glucose monitor.

A continuous glucose monitoring (CGM) optimization program can help patients with diabetes become more self-aware and give health care providers additional insight into glycemic control, according to new research presented at the Endocrine Society’s 2024 annual meeting, held June 1 to 4 in Boston, Massachusetts.1

According to data from the CDC, nearly 40 million people in the United States have a diagnosed case of diabetes.2 Complication from the disease can include microvascular, macrovascular, and neuropathic issues, which is why managing the condition is crucial to improving outcomes. CGM is a key tool in managing diabetes, as it provides a comprehensive and detailed...

Today's Sponsors


Today's Sponsor


Topics: Conferences / Podcast, Digital Health, Technology, Trends, Wearables
Apps and Wearables Bridge Gaps in Mental Health Care
Will the Apple Watch, Samsung Galaxy or Oura Rings Become “Intelligent Guardians” For Health?
Popular Wearables Can Help Doctors Manage Medication in Patients with Heart Disease
Apple secures win in EKG patent fight
Accurate and continuous remote monitoring of step length can be sensitive marker for neurological diseases and aging

Share This Article